Inquiry Basket
N-(2-(2, 4-Difluorophenoxy)ethyl)-4-formylbenzamide is a linker for antibody-drug-conjugation (ADC).
| Catalog Number | Size | Price | Quantity | |
|---|---|---|---|---|
| BADC-00547 | -- | $-- | Inquiry |
N-(2-(2,4-Difluorophenoxy)ethyl)-4-Formylbenzamide is an important compound in the development of targeted therapies, particularly in the area of cancer treatment. The molecule's structural features, including the formylbenzamide group, allow for selective interactions with specific receptors or enzymes involved in tumor growth and metastasis. This makes it a key candidate for the design of targeted drug delivery systems that can deliver therapeutic agents directly to cancer cells, minimizing damage to healthy tissues and improving the efficacy of treatment.
One significant application of N-(2-(2,4-Difluorophenoxy)ethyl)-4-Formylbenzamide is in the design of small-molecule inhibitors targeting key enzymes and signaling pathways in cancer. The difluorophenoxyethyl group provides hydrophobic interactions and improves the compound's binding affinity to the target protein. By inhibiting these critical enzymes, such as kinases or proteases involved in cancer progression, the compound can potentially slow tumor growth, reduce metastasis, and enhance the overall therapeutic outcome of cancer treatments.
Additionally, N-(2-(2,4-Difluorophenoxy)ethyl)-4-Formylbenzamide plays a role in the development of diagnostic imaging agents. Its unique structure and functional groups make it suitable for modification and conjugation to imaging agents, such as fluorescent dyes or radionuclides, allowing for the specific detection of cancerous tissues. This application is particularly useful for monitoring tumor progression, evaluating the effectiveness of treatments, and guiding surgical interventions in real-time, offering precision medicine approaches in oncology.
The compound is also explored for its potential use in the design of novel anti-inflammatory agents. The formylbenzamide structure has been shown to interact with key inflammatory mediators, such as cyclooxygenases or inflammatory cytokines. By modulating these pathways, N-(2-(2,4-Difluorophenoxy)ethyl)-4-Formylbenzamide could serve as a lead compound in the development of new drugs for the treatment of chronic inflammatory diseases, including rheumatoid arthritis and inflammatory bowel disease, where targeting inflammation at the molecular level offers potential therapeutic benefits.
Customer Support
Providing excellent 24/7 customer service and support
Project Management
Offering 100% high-quality services at all stages
Quality Assurance
Ensuring the quality and reliability of products or services
Global Delivery
Ensuring timely delivery of products worldwide
BOC Sciences offers comprehensive services for ADC manufacturing, including antibody modification, linker chemistry, payload conjugation, and formulation development. In particular, our payload-linker customization service offers a convenient and fast raw material channel for many ADC researchers.
BOC Sciences provides one-stop site-specific conjugation services for amino acids, glycans, unnatural amino acids, and short peptide tags. In addition, cysteine conjugation, lysine conjugation, enzymatic conjugation, thio-engineered antibody can also be obtained quickly.
BOC Sciences offers a full range of linkers, including peptide linkers, PEG linkers, click chemistry, PROTAC linkers, non-cleavable linkers, etc. We also provide custom development services for chemically labile linkers and enzymatically cleavable linkers.
